UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action

American journal of transplantation, 2006-05, Vol.6 (5p1), p.859-866

Pescovitz, M. D.

2006

Volltextzugriff (PDF)

Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

American journal of transplantation, 2013-01, Vol.13 (1), p.136-145

2013

Volltextzugriff (PDF)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Volltextzugriff (PDF)

Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

American journal of transplantation, 2009-05, Vol.9 (5), p.1205-1213

2009

Volltextzugriff (PDF)

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

American journal of transplantation, 2007-06, Vol.7 (6), p.1506-1514

2007

Volltextzugriff (PDF)

Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients

American journal of transplantation, 2005-12, Vol.5 (12), p.2894-2900

2005

Volltextzugriff (PDF)

Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients

American journal of transplantation, 2010-08, Vol.10 (8), p.1881-1888

2010

Volltextzugriff (PDF)

An Assessment of Herpesvirus Co‐infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes

American journal of transplantation, 2009-02, Vol.9 (2), p.374-381

2009

Volltextzugriff (PDF)

Phase 1 Dose‐Escalation Study of CP‐690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics

American journal of transplantation, 2008-08, Vol.8 (8), p.1711-1718

2008

Volltextzugriff (PDF)

Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation

American journal of transplantation, 2016-04, Vol.16 (4), p.1266-1275

2016

Volltextzugriff (PDF)

A Randomized, Double‐Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients

American journal of transplantation, 2009-10, Vol.9 (10), p.2324-2330

2009

Volltextzugriff (PDF)

Valganciclovir: Recent Progress

American journal of transplantation, 2010-06, Vol.10 (6), p.1359-1364

Pescovitz, M. D.

2010

Volltextzugriff (PDF)

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2811-2815

2000

Volltextzugriff (PDF)

A Phase I/II Randomized Open‐Label Multicenter Trial of Efalizumab, a Humanized Anti‐CD11a, Anti‐LFA‐1 in Renal Transplantation

American journal of transplantation, 2007-07, Vol.7 (7), p.1770-1777

2007

Volltextzugriff (PDF)

Differential Pharmacokinetic Interaction of Tacrolimus and Cyclosporine on Everolimus

Transplantation proceedings, 2006-12, Vol.38 (10), p.3456-3458

2006

Volltextzugriff (PDF)

C4d Deposition and Clearance in Cardiac Transplants Correlates With Alloantibody Levels and Rejection in Rats

American journal of transplantation, 2006-05, Vol.6 (5p1), p.923-932

2006

Volltextzugriff (PDF)

Once‐Daily Tacrolimus Extended‐Release Formulation: 1‐Year Post‐Conversion in Stable Pediatric Liver Transplant Recipients

American journal of transplantation, 2007-06, Vol.7 (6), p.1609-1615

2007

Volltextzugriff (PDF)

Analysis and clinical correlation of genetic variation in cytomegalovirus

Transplant infectious disease, 2012-04, Vol.14 (2), p.132-140

2012

Volltextzugriff (PDF)

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

The New England journal of medicine, 1998-01, Vol.338 (3), p.161-165

1998

Volltextzugriff (PDF)

Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients

Transplant infectious disease, 2010-06, Vol.12 (3), p.195-203

2010

Volltextzugriff (PDF)

Giving Birth to an Operation: Laparoscopic Live Donor Nephrectomy with Vaginal Extraction. Is This Misconceived?

American journal of transplantation, 2010-06, Vol.10 (6), p.1347-1348

2010

Volltextzugriff (PDF)

A cost too high to bear? Prophylaxis versus preemptive therapy to prevent post-transplantation cytomegalovirus

Kidney international, 2007-10, Vol.72 (8), p.912-913

Pescovitz, M.D.

2007

Volltextzugriff (PDF)

Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients

Transplantation proceedings, 2009-11, Vol.41 (9), p.3655-3661

2009

Volltextzugriff (PDF)

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

The Lancet (British edition), 1997-12, Vol.350 (9093), p.1729-1733

1997

Volltextzugriff (PDF)

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

Transplantation, 2001-12, Vol.72 (12), p.1915

2001

Volltextzugriff (PDF)

1 – 25 von 388

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Englisch
(388)
Japanisch
(37)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(248)
Life Sciences & Biomedicine
(245)
Humans
(217)
Biological And Medical Sciences
(187)
Medical Sciences
(166)
Male
(147)
Female
(139)
Surgery
(113)
Adult
(103)
Transplantation
(103)
Immunology
(94)
Middle Aged
(72)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(69)
Animals
(67)
Child
(58)
Pharmacology. Drug Treatments
(56)
Adolescent
(54)
Fundamental And Applied Biological Sciences. Psychology
(50)
Child, Preschool
(40)
Fundamental Immunology
(39)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action

Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients

Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients

An Assessment of Herpesvirus Co‐infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes

Phase 1 Dose‐Escalation Study of CP‐690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics

Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation

A Randomized, Double‐Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients

Valganciclovir: Recent Progress

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

A Phase I/II Randomized Open‐Label Multicenter Trial of Efalizumab, a Humanized Anti‐CD11a, Anti‐LFA‐1 in Renal Transplantation

Differential Pharmacokinetic Interaction of Tacrolimus and Cyclosporine on Everolimus

C4d Deposition and Clearance in Cardiac Transplants Correlates With Alloantibody Levels and Rejection in Rats

Once‐Daily Tacrolimus Extended‐Release Formulation: 1‐Year Post‐Conversion in Stable Pediatric Liver Transplant Recipients

Analysis and clinical correlation of genetic variation in cytomegalovirus

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients

Giving Birth to an Operation: Laparoscopic Live Donor Nephrectomy with Vaginal Extraction. Is This Misconceived?

A cost too high to bear? Prophylaxis versus preemptive therapy to prevent post-transplantation cytomegalovirus

Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

Suchergebnisse filtern